A cross-city analysis of NHSBSA dispensing revenue data by PharmSee reveals a consistent pattern: independent pharmacies generate higher dispensing revenue per active branch than major chain operators in four of the five English cities examined. The gap ranges from approximately £19,000 in Liverpool to £60,000 in Newcastle.
The data
PharmSee analysed pharmacy-level dispensing revenue within a three-mile radius of each city centre, classifying branches as "independent" or "chain" based on NHSBSA contractor name data. Only active branches (those with recorded dispensing revenue above zero in the most recent quarter) are included.
| City | Independent avg revenue | Chain avg revenue | Gap | Independent branches | Chain branches |
|---|---|---|---|---|---|
| Newcastle (NE1) | £155,742 | £95,637 | +£60,105 | 48 | 15 |
| Leeds (LS1) | £105,396 | £63,949 | +£41,447 | 57 | 10 |
| Manchester (M1) | £115,433 | £90,379 | +£25,054 | 66 | 25 |
| Liverpool (L1) | £121,301 | £102,350 | +£18,951 | 64 | 23 |
| Plymouth (PL1) | £115,216 | £129,627 | −£14,411 | 25 | 10 |
In four of five cities, independent pharmacies generate materially more dispensing revenue per branch than their chain counterparts. Plymouth is the exception, where chain pharmacies outperform independents by approximately £14,400 per branch.
Why the gap exists
Several structural factors help explain the independent revenue advantage:
Zero-revenue branch concentration. The analysis excludes zero-revenue branches from both categories, but the underlying pattern is relevant: chain operators carry a higher proportion of zero-revenue registered branches than independents. In Newcastle, 52.9% of Boots branches and 77.8% of Lloyds branches recorded zero revenue, compared with 7.0% of independents. This suggests that the chain branches still active in a catchment may be in lower-revenue locations — the higher-revenue sites having been retained in the register without active dispensing.
Location selection. Independent pharmacies are often located in residential neighbourhoods with established patient bases, while chain pharmacies frequently occupy high street or retail park locations where footfall is higher but prescription capture may be lower. An independent pharmacy embedded in a housing estate with a local GP practice within walking distance may capture a higher proportion of that practice's prescriptions than a chain branch in a shopping centre.
Patient loyalty. Independent pharmacies often benefit from long-standing relationships with local patients and GP practices. Patients who have used the same pharmacy for years are less likely to switch, creating a stable prescription base that translates into consistent dispensing revenue.
Service mix. Some independent pharmacies have developed specialist dispensing services — monitored dosage systems, care home supply, appliance dispensing — that generate higher per-item revenue than standard prescription dispensing. These services are available to chains too, but independents may be more likely to pursue them as a competitive differentiator.
The Plymouth exception
Plymouth's reversal of the pattern — chains outperforming independents by £14,411 per branch — may reflect the city's distinctive pharmacy landscape. With a GP-to-pharmacy ratio of 1.49:1 (the highest PharmSee has measured), Plymouth has fewer pharmacies relative to GP practices than any other city in the dataset. In this environment, chain branches may capture a larger share of prescription volume simply because there are fewer independent alternatives nearby.
Plymouth's chain pharmacy estate also appears more operationally active than in other cities: the city's 18.6% zero-revenue rate is lower than Newcastle's 25.9% or Exeter's 30.8%, suggesting a cleaner register with fewer inactive entries skewing the data.
What the data does not show
This analysis captures NHS dispensing revenue only. It does not include:
- Retail sales (cosmetics, toiletries, health products), which are typically a larger revenue component for chain pharmacies than independents
- Private dispensing (travel vaccines, private prescriptions)
- Service income (Pharmacy First consultations, NHS Health Checks, smoking cessation)
- Costs and profitability — higher revenue does not necessarily mean higher profit. Chain pharmacies benefit from centralised procurement and hub-and-spoke dispensing that may deliver better margins per item despite lower headline revenue.
The independent revenue advantage should therefore be read as a dispensing-specific finding, not a general profitability claim.
What it means
For independent pharmacy owners, the data provides a useful benchmark: in most urban catchments, independent branches are generating more dispensing revenue per site than chain operators in the same area. This supports the sector's argument that independent pharmacies punch above their weight in NHS service delivery.
For pharmacists considering career moves, the data suggests that independent pharmacy branches may offer more clinical activity per site — higher prescription volumes generally mean more patient interactions, more Pharmacy First consultations, and more opportunities to develop clinical skills.
Explore pharmacy-level data at PharmSee's pharmacy search or compare city-level market data at the location analysis tool.
Methodology
Revenue figures are derived from PharmSee's analysis of NHSBSA dispensing contractor data (most recent available quarter), queried at a three-mile radius from each city centre postcode. Chain classification uses contractor name matching against known chain names (Boots, Lloyds, Well, Asda, Tesco, Superdrug, Morrisons, Rowlands, Cohens, Weldricks, Day Lewis). All other active branches are classified as independent. This method may misclassify a small number of branches where the contractor name does not match the operating chain.
Sources: NHSBSA dispensing data, NHS Digital pharmacy register, PharmSee database (13 April 2026).